All stock lists
Unlock the score
Hepion Pharmaceuticals, Inc. (HEPA)
United States · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.13-0.01 (-8.50%)
Insider Score
/ 100
HEPA Insider Score
Hepion Pharmaceuticals, Inc. has a live Insider Score.
Scored on 7 qualifying trades from 6 insiders in the last 90 days.
HEPA Stock Insider Trading Activity
HEPA stock’s insider trading shows 7 purchases for an estimated $835.00K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days7 qualifying buys6 insiders$835.00K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fisher Danina Director | Buy | 200,000 | $0.05 | $10.00K | New | 200,000 | Sep 29, 2026 | BFirst BuyDilution | Form 4 |
| Stetz Gary S. CEO | Buy | 2,000,000 | $0.05 | $100.00K | 160% | 3,250,000 | Aug 3, 2026 | ACluster BuyStake DoublerDilution | Form 4 |
| LoPriore Vincent S Director | Buy | 2,000,000 | $0.05 | $100.00K | 14.0% | 16,250,000 | Aug 3, 2026 | CCluster BuyDilution | Form 4 |
| Purcell Michael J. Director | Buy | 2,000,000 | $0.05 | $100.00K | 160% | 3,250,000 | Aug 3, 2026 | BCluster BuyStake DoublerDilution | Form 4 |
| Appajosyula Sireesh COO | Buy | 2,000,000 | $0.05 | $100.00K | 160% | 3,250,000 | Aug 3, 2026 | ACluster BuyStake DoublerDilution | Form 4 |
| LoPriore Vincent S Director | Buy | 8,000,000 | $0.05 | $400.00K | 128% | 14,250,000 | Aug 3, 2026 | BCluster BuyStake DoublerDilution | Form 4 |
| Stetz Gary S. II Director | Buy | 500,000 | $0.05 | $25.00K | New | 500,000 | Aug 3, 2026 | BCluster BuyFirst BuyDilution | Form 4 |
| Stetz Gary S. CEO | Buy | 1,250,000 | $0.04 | $50.00K | New | 1,250,000 | Apr 21, 2026 | ACluster BuyFirst BuyDilution | Form 4 |
| LoPriore Vincent S Director | Buy | 5,000,000 | $0.04 | $200.00K | New | 5,000,000 | Apr 21, 2026 | ACluster BuyFirst BuyDilution | Form 4 |
| Purcell Michael J. Director | Buy | 1,250,000 | $0.04 | $50.00K | New | 1,250,000 | Apr 21, 2026 | BCluster BuyFirst BuyDilution | Form 4 |
| Appajosyula Sireesh Director | Buy | 1,250,000 | $0.04 | $50.00K | New | 1,250,000 | Apr 21, 2026 | BCluster BuyFirst BuyDilution | Form 4 |
| LoPriore Vincent S Director | Buy | 1,250,000 | $0.04 | $50.00K | 25.0% | 6,250,000 | Apr 21, 2026 | CCluster BuyFirst BuyDilution | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.